Pityriasis Alba

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pityriasis Alba trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

Active — Not RecruitingNot Applicable

NCT03443765

Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba

Pityriasis alba (PA) is a common, benign skin disorder occurring predominantly in children and adolescents. It is characterized by ill-defined hypopigmented mac…

Uzbekistan280 participantsStarted 2017-05-01

Treatment: Detection of Plasma levels of 25(OH) vitamin D by ELISA technique, Detection of Total serum immunoglobulin E by ELISA technique

UnknownPhase 2/3

NCT03834935

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

Pityriasis alba (PA) is a common benign skin disorder, that usually affects children and adolescents of darker phototypes. A history of atopic dermatitis is a w…

Lebanon40 participantsStarted 2019-03-01

Treatment: Elidel (pimecrolimus 1%), Cold Cream

CompletedPhase 4

NCT01388517

Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba

Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, trend to relapse and aesthetic impact. Currently, no treat…

Mexico39 participantsStarted 2008-01

Treatment: Tacrolimus, Calcitriol